| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 1,389,613 | 1,619,275 | 1,498,495 | | Cost of Revenue | 1,173,319 | 1,330,912 | 1,201,337 | | | Gross Profit | 216,294 | 288,363 | 297,158 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 121,897 | 126,848 | 116,482 | | Non Recurring | 17,653 | 390 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 76,744 | 161,125 | 180,676 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 20,534 | 42,696 | 36,890 | | Earnings Before Interest And Taxes | 97,278 | 203,821 | 217,566 | | Interest Expense | 139 | 456 |
-
| | Income Before Tax | 97,139 | 203,365 | 217,566 | | Income Tax Expense | 16,293 | 53,892 | 63,701 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 80,846 | 149,473 | 153,865 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 80,846 | 149,473 | 153,865 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $80,846 | $149,473 | $153,865 |
|
1.48% Nasdaq 
Income Statement
